-
- Sign In
- Tests
-
Invitae testsFollow-up testingFrequently ordered panels
- How to order
- Resources
-
Clinical resourcesEducational materialsWorking together
- Technology
-
Our technologyA new gold standardData sharing
- FAQ
- FOR PATIENTS
- CONTACT
- FAQs / SUPPORT
Welcome to the
Genetics Resource Hub
The field of genetics is constantly evolving as new data emerges linking genes and disease. As your partner in genetic testing, we’re working to gather the most up-to-date resources in one central location: this Genetics Resource Hub.
The hub also includes resources to help educate the rest of your patients’ healthcare team—and your patients themselves.
This resource page includes:
CancerGene Connect
A complimentary risk assessment and pedigree tool for all clinicians.
Invitae clinic notes
Each week, Invitae develops and shares a clinic note for a not-so-common gene.
Clinical Consult Services
Our team of genetic counselors shares well-referenced clinic notes.
Recent webinars
Targeted treatments for the genetic epilepsies: Clinical cases
Katie Angione, MD, CGC, and Lacey Smith, MD, CGC, discuss clinical cases in the management and targeted treatment of genetic childhood epilepsies.
Panels and exomes: Diagnostic yield and detection of childhood epilepsy
Joseph Sullivan, MD, and Swaroop Aradhya, PhD, discuss diagnostic yield in the detection of childhood epilepsy.
Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria
Keith Nykamp, PhD, discusses Invitae’s innovative approach to genetic variant classification, published in the October 2017 issue of Genetics in Medicine.
The future of genetic testing: Making genetic information affordable and accessible to all
Randy Scott, PhD, discusses the future of genetic testing and how we can make genetic information affordable and accessible to all.
A diagnostic odyssey: Why early and accurate genetic testing in epilepsy is so important
Brenda Porter, MD, PhD, and Kim Nye discuss the importance of early and accurate genetic testing in epilepsy.
Next-generation sequencing (NGS)-based detection of deletions and duplications in heritable cardiovascular conditions
Matteo Vatta Ph.D., FACMG, discusses how next-generation sequencing (NGS) can detect both del/dup events and sequence alterations, assesses the advantages of NGS-based del/dup detection, including improved coverage compared to traditional techniques, and describes the frequency of del/dup events in heritable cardiovascular conditions.
Oncology clinical tools
Hereditary cancer risks and references
HBOC management guidelines
Colorectal cancer management guidelines
Cardiology clinical tools and management gudelines
Aortopathy
Arrhythmia and cardiomyopathy
Familial hypercholesterolemia
Referral letters to reach more patients
You see patients all day long, but what about the patients that are not getting referred to you or another genetics professional?
We have developed template letters that you can share with ordering clinicians in your clinic or institution that highlight the importance of genetic testing, the types of patients who should be referred, and space to add a personal note and your contact information.
Clinician videos
As genetic counselors and clinicians work closer and closer together, we have partnered with OncLive to bring you several videos to help clinicians understand all aspects of genetic testing for breast cancer.
Value of a genetic counselor in genetic testing
Claudine J. Isaacs, MD
Choosing a smaller or larger multi-gene panel
Claudine J. Isaacs, MD; Adam M. Brufsky, MD; Harold J. Burstein, MD, PhD
Genetic risk assessment for breast cancer
Harold J. Burstein, MD, PhD; Adam M. Brufsky, MD; Claudine J. Isaacs, MD
